血栓彈力圖市場－按類型、應用、最終用戶和地區分類：市場規模、佔有率、前景和機會分析（2025-2032 年）

Thromboelastography Market, By Type, By Application, By End User, and By Region Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032

出版日期: 2026年04月28日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

血栓彈力圖（TEG）市場預計到 2026 年將達到 7.962 億美元，到 2033 年將達到 13.038 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 7.3%。

分析範圍		分析詳情
基準年	2025	市場規模（2026 年）	7.962億美元
效能數據	2020-2024	預測期	2026-2033
預測期（2026-2033 年）複合年成長率	7.30%	預計金額（2033 年）	13.038億美元

血栓彈力圖在預防嚴重創傷或手術期間可能發生的大量失血和出血方面發揮著至關重要的作用。由於血栓彈力圖 (TEG) 可以對血小板、酶、纖維蛋白原和其他凝血因子之間的關係進行全面的體外分析，因此它常用於心血管手術、器官移植和動靜脈畸形手術等預計失血量超過循環血容量 40% 的手術中。血小板功能圖譜分析可以評估服用抗血小板藥物（如Clopidogrel和阿斯匹靈）患者的血小板活性。這可以透過將 TEG 納入麻醉前評估來實現。

市場動態

預計在預測期內，市場相關人員為開發新技術而加大的投入將推動全球血栓彈力圖市場成長。例如，美國國家醫學圖書館於2022年2月20日發表的一篇論文指出，凝血障礙對耳鼻喉科和頭頸外科（ENT）的診斷和治療帶來了更多挑戰。對於高凝血狀態和低凝血狀態的患者，仔細評估止血能力的性質對於凝血障礙的治療至關重要。黏彈性測試（VET），例如血栓彈力圖（TEG）和旋轉血栓彈力圖（ROTEM），多年來一直被用作血液成分治療（BCT）的指南技術。 VET廣泛應用於創傷性凝血障礙和出血性疾病的診斷和治療。

預計在預測期內，美國FDA等監管機構新核准數量增加將推動全球血栓彈力圖市場成長。例如，2021年1月11日，從事醫療設備和產品研發的跨國公司雅培公司（Abbott Laboratories）獲得了FDA 510(k)批准，其首個用於快速攜帶式腦震盪血液檢測的產品即為雅培的i-STAT Alinity手持式設備。該設備用於輔助診斷輕度創傷性腦損傷（TBI），也稱為腦震盪。插入血漿樣本後15分鐘即可獲得檢測結果。

本報告的主要特點

本報告揭示了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要公司採取的競爭策略的重要見解。
本節根據公司概況、產品系列、主要趨勢、財務績效和策略等各種參數，對全球血栓彈力圖市場的主要公司進行介紹。
本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、技術更新、市場擴張和行銷策略做出明智的決策。
《全球血栓彈力圖市場》報告針對業界廣泛的相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過分析全球血栓彈力圖市場中使用的各種策略矩陣來促進決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 南非
- 中非
- 北非

第8章競爭情勢

熱圖分析
市佔率分析
- Lepu Medical Technology（Beijing）Co.,Ltd.
- Render Biotech Co.
- Haemonetics Corporation
- TA Instruments
- HemaCore LLC
- 5-Diagnostics
- Xenometrix AG
- Framar Hemologix srl
- Instrumentation Laboratory
- Medirox AB
- Diagnostica Stago
- Life Diagnostica
- SYCOmed eK
- Nordic Biomarker
- Shenzhen Ultra-Diagnostics Biotec. Co., Ltd.
分析師意見

第9章

分析方法
關於 Coherent Market Insights

簡介目錄

Product Code: CMI2371

Thromboelastography Market is estimated to be valued at USD 796.2 Mn in 2026 and is expected to reach USD 1,303.8 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 796.2 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	7.30%	2033 Value Projection:	USD 1,303.8 Mn

The thromboelastography protects against the severe blood loss or hemorrhage occurred during severe injury or during a surgery. Thromboelastography (TEG) is more frequently used in cardiac surgery, organ transplants, and arteriovenous malformation surgeries where the anticipated blood loss is greater than 40% of the circulating blood volume because it performs an in vitro analysis of the relationship between platelets, enzymes, fibrinogen, and other coagulation elements in a comprehensive manner. Through platelet mapping, patients using antiaggregants like clopidogrel or aspirin can have their platelet activity assessed. This is made possible by include TEG in the pre-anesthetic assessment.

Market Dynamics

Increasing initiatives in developing new methods by market players is expected to boost the growth of global thromboelastography market over the forecast period. For instance, on February 20, 2022, an article published in national library of medicine, asserted that Coagulopathies pose additional diagnostic and therapeutic difficulties in the field of otolaryngology-head and neck surgery (ENT). Management of coagulopathies in both hyper- and hypocoagulable individuals necessitates careful consideration of the nature of hemostatic competence. Viscoelastic tests (VETs) such as thromboelastography (TEG) and rotational thromboelastometry (ROTEM) have long been methods of guiding blood component therapy (BCT). VETs have been widely adopted for the diagnosis and management of trauma-induced coagulopathy and bleeding conditions.

Increasing in the rate of new approvals by regulatory authorities such as the U.S. FDA is likely to boost the growth of global thromboelastography market over the forecast period. For instance, on January 11, 2021, Abbott Laboratories is a multinational company engaged in manufacturing and research of medical devices and health care products. Abbott received an FDA 510(k) clearance for the first rapid handheld blood test for concussion. The i-STAT Alinity handheld device from Abbott will be used to provide the test to help diagnose mild traumatic brain injury (TBI), also known as concussion. The test results are available 15 minutes after inserting a plasma sample.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global thromboelastography market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies
Key companies covered as a part of this study include Lepu Medical Technology (Beijing) Co.,Ltd., Render Biotech Co., Haemonetics Corporation, TA Instruments, HemaCore LLC, 5-Diagnostics, Xenometrix AG, Framar Hemologix srl, Instrumentation Laboratory, Medirox AB, Diagnostica Stago, Life Diagnostica, SYCOmed e.K., Nordic Biomarker, and Shenzhen Ultra-Diagnostics Biotec. Co., Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global thromboelastography market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global thromboelastography market

Detailed Segmentation:

Global Thromboelastography Market, by Type (Revenue, USD Mn, 2021 - 2033)
Standard (kaolin)
Rapid TEG
Native TEG
Heparinase
Functional Fibrinogen
Platelet Mapping
Global Thromboelastography Market, by Application (Revenue, USD Mn, 2021 - 2033)
Cardiopulmonary Bypass
Liver Surgery
Trauma surgery
Obstetrics
Global Thromboelastography Market, by End User (Revenue, USD Mn, 2021 - 2033)
Hospitals
Blood Banks
Academic Institutes
Others (Research Laboratories, Research Institutes)
Global Thromboelastography Market, By Region (Revenue, USD Mn, 2021 - 2033)
North America
- By Country:
  - U.S.
  - Canada
Latin America
- By Country:
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- By Country:
  - U.K.
  - Germany
  - Italy
  - Spain
  - France
  - Russia
  - Rest of Europe
Asia Pacific
- By Country:
  - Australia
  - India
  - China
  - Japan
  - ASEAN
  - South Korea
  - Rest of Asia Pacific
Middle East
- By Country:
  - GCC
  - Israel
  - Rest of Middle East
Africa
- By Country/Region:
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
Lepu Medical Technology (Beijing) Co.,Ltd *
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Render Biotech Co.
Haemonetics Corporation
TA Instruments
HemaCore LLC
5-Diagnostics
Xenometrix AG
Framar Hemologix srl
Instrumentation Laboratory
Medirox AB
Diagnostica Stago
Life Diagnostica
SYCOmed e.K.
Nordic Biomarker
Shenzhen Ultra-Diagnostics Biotec. Co., Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunity
Impact Analysis
Key Developments
Industry Trends
Regulatory Scenario
Recent Product Approval/Launches
PEST Analysis
Porter's Analysis

4. Global Thromboelastography Market, By Type, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Standard (kaolin)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Rapid TEG
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Native TEG
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Heparinase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Functional Fibrinogen
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Platelet Mapping
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

5. Global Thromboelastography Market, By Application, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Cardiopulmonary Bypass
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Liver Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Trauma surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Obstetrics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

6. Global Thromboelastography Market, By End User, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Blood Banks
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Others (Research Laboratories, Research Institutes)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

7. Global Thromboelastography Market, By Region, 2021 - 2033 (US$ Million)

Introduction
- Market Share Analysis, By Region, 2026 and 2033(%)
- Y-o-Y Growth Analysis, For Regions, 2022 - 2033
- Regional Trends
North America
- Market Size and Forecast, By Type, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Application, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033 (US$ Mn)
  - U.S.
  - Canada
Latin America
- Market Size and Forecast, By Type, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Application, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033 (US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Market Size and Forecast, By Type, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Application, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033 (US$ Mn)
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Type, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Application, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033 (US$ Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Type, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Application, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033 (US$ Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, By Type, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Application, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Region/Country, 2021 - 2033 (US$ Mn)
  - South Africa
  - Central Africa
  - North Africa

8. Competitive Landscape

Heat Map Analysis
Market Share Analysis
- Lepu Medical Technology (Beijing) Co.,Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Render Biotech Co.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Haemonetics Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- TA Instruments
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- HemaCore LLC
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- 5-Diagnostics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Xenometrix AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Framar Hemologix srl
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Instrumentation Laboratory
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Medirox AB
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Diagnostica Stago
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Life Diagnostica
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- SYCOmed e.K.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Nordic Biomarker
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Shenzhen Ultra-Diagnostics Biotec. Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
Analyst Views